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Abstract
Background Oncoplastic breast surgery is an evolving disci-
pline in the surgical treatment of breast cancer aimed to
improve the outcome.
Methods Oncoplastic breast surgery was performed between
January 2008 and December 2010 on 72 women with 74
breast cancers selected from a population of 1,018 primary
breast cancer patients. Careful preoperative planning revealed
the possibility of partial breast reconstruction with volume
reduction, volume displacement or volume replacement de-
pending on breast size as well as tumour size and location.
Data were registered consecutively.
Results The surgical plan was successful in all but one case,
where a mastectomy had to be performed during the primary
surgery. In 53 cases, a contralateral mammoplasty was per-
formed during the operation to achieve symmetry. During the
follow-up period until November 2011, only one patient
needed corrective surgery. Final histopathological examina-
tion indicated that seven cases required extended resection and
three cases required a mastectomy. Five patients experienced
delayed wound healing, although complications requiring
further surgery occurred for the reconstructed breast in four
cases, the contralateral breast in three cases and the axilla after
exaeresis in two cases because of haematoma. Such compli-
cations led to slight delay in adjuvant therapy for four
patients.
Conclusions This study demonstrates that it is feasible to im-
plement oncoplastic breast surgery into daily clinical practice as
a supplement to conventional breast cancer surgery. As such,
oncoplastic breast surgery may provide a markedly better out-
come than breast-conserving surgery in terms of shape and
symmetry without compromising the surgical margins.
Level of Evidence: Level IV, prognostic/risk study.
Keywords Breast cancer . Oncoplastic surgery .Methods of
reconstruction . Surgical margins . Postoperative
complications . Partial breast reconstruction
Introduction
In recent years, the discipline or subspecialty of oncoplastic
breast surgery has grown considerably as breast and plastic
surgeons increasingly work together to surgically treat breast
cancer patients [1–10]. The reasoning behind oncoplastic
breast surgery is twofold: to ensure that patients are treated
with radical cancer surgery and to achieve the best possible
cosmetic and resilient result, including a naturally shaped
breast with acceptable symmetry [8–16]. Oncoplastic breast
surgery involves partial breast reconstruction and, if indicated,
contralateral surgery all in one surgical procedure. Secondary
reconstructive procedures are rarely required.
As a breast cancer treatment, oncoplastic breast surgery is
expected to be similar to conventional breast-conserving sur-
gery with regards to resection margins, locoregional recurrence
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and metastatic disease [6, 17–21]. Nevertheless, it should be
noted that specific studies investigating longterm safety
concerning locoregional recurrence and metastatic disease after
oncoplastic breast surgery are limited. Cancer surveillance after
partial breast reconstruction seems not to be impaired [22].
As oncoplastic breast surgery is often more complex and
involves both breasts, the occurrence of early postoperative
complications could be expected to be higher than the occur-
rence of complications after breast-conserving surgery [18].
The primary concern for postoperative complications is the
potential delay in commencement of adjuvant therapy. In a
recent review by McIntosh and O’Donogue, they find that the
available data were inadequate to conclude whether or not
complications after oncoplastic breast surgery delay delivery
of adjuvant therapy compared with conventional breast-
conserving surgery [18].
Oncoplastic breast surgery is the application of surgical
techniques from conventional breast-conserving surgery as well
as plastic and reconstructive surgery, resulting in an improved
aesthetic outcome for breast cancer patients. Thus, oncoplastic
breast surgery may reduce the number of overall breast cancer
patients undergoing a mastectomy [4, 5, 11, 15, 21].
Previous studies have shown that, compared with mastec-
tomy, breast-conserving surgery has less of an impact on a
patient’s body image, as well as psychosocial and social
aspects of life [13, 15, 23]. By providing a better aesthetic
outcome than tumour resection alone, oncoplastic breast sur-
gerymay also improve quality of life for breast cancer patients
after surgical treatment [1, 3, 13].
Several factors, such as tumour size, tumour location and
size of the affected breast, need to be addressed when consid-
ering oncoplastic surgery for partial breast reconstruction [3,
4, 11, 14–16, 21]. Furthermore, the choice of reconstruction
method determines the need for surgery on the contralateral
breast to ensure symmetry. Patient preference for a particular
method of reconstruction and the sentiment towards possible
contralateral surgery must also be considered [14, 16, 21].
Implementation of oncoplastic breast surgery into daily
clinical practice will undoubtedly take time [1, 2]. Our team
of plastic and reconstructive surgeons and breast surgeons
continues to develop and perfect surgical techniques since
routine oncoplastic breast surgery was introduced at our prac-
tice. Successful implementation also involves learning to de-
termine which patients are suitable for oncoplastic breast
surgery and to find the most suitable technique of oncoplastic
breast surgery in each patient.
In the current study, we present and evaluate our strategy in
the surgical planning of oncoplastic breast surgery in terms of
different reconstructions methods related to tumour size, tu-
mour location and size of the breast. Furthermore, we present
and evaluate results of surgical radicality in terms of resection
margins, surgery due to insufficient resection margins and late
positive sentinel nodes and early postoperative complications.
Materials and methods
Setting
In January 2008, oncoplastic breast surgery was introduced
for selected patients with primary breast cancer. The surgical
team consisted of breast surgeons as well as plastic and
reconstructive surgeons from the public hospital Sydvest
Sygehus, Esbjerg, DK, Surgical Department, Section of
Breast Surgery and Section of Plastic and Reconstructive
Surgery, as well as the private hospital Privathospitalet
Aleris-Hamlet, Copenhagen, DK, Department of Breast and
Plastic Surgery. In October 2010, oncoplastic breast surgery
was also introduced at the public hospital Sygehus
Soenderjylland, Aabenraa, DK, Department of Surgery,
Section of Breast Surgery.
The two public hospitals recruited their patients from their
uptake areas whereas patients actively chose the private hos-
pital regardless of place of residence.
A team of five plastic surgeons and two breast surgeons
performed the surgery at the public hospitals, while a team of
two plastic surgeons and two breast surgeons performed the
surgery at the private hospital.
Patient selection
Patients were diagnosed with primary breast cancer by clinical
mammography and biopsy. They were examined by a breast
surgeon. If conventional breast-conserving surgery was pre-
dicted to result in an unfavourable cosmetic outcome, or if
mastectomy was the primary recommendation based on tu-
mour size and location rather than for oncological reasons,
then the patient was informed of the alternative of oncoplastic
breast surgery. Potential candidates for oncoplastic breast
surgery were hence referred to a plastic and reconstructive
surgeon for additional consultation to assess possible recon-
struction methods. If oncoplastic breast surgery was deemed
suitable, planning for immediate partial reconstruction and
optional contralateral surgery to ensure symmetry ensued.
Patients for whom radiation therapy was contraindicated as
well as patients with multicentric tumours or extensive ductal
carcinoma in situ (DCIS) were excluded. Known systemic
dissemination of the cancer was regarded as a relative contra-
indication. Age, comorbidity, smoking, alcohol habits and
overweight status were not considered contraindications for
oncoplastic breast surgery.
Patients
Patients were selected from the general population of breast
cancer patients who were scheduled to have surgery between
January 2008 and December 2010 (Table 1). Oncoplastic
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breast surgery was performed on 72 patients with a total 74
primary breast carcinomas (two cases with bilateral breast
cancer). Oncoplastic breast surgery was performed on 44
patients at Sydvestjysk Sygehus, 23 patients at Aleris-
Hamlet Privathospitaler and 5 patients at Sygehus
Soenderjylland. Nineteen patients were referred from the
mammography screening programme, whereas 53 patients
were referred by general practitioners or others specialists
after detection of a palpable breast tumour or a mammography
showing areas of suspected malignancy for further evaluation.
The mean age was 53, ranging between 31 and 69 years of
age. Invasive ductal carcinomas comprised 87 % of tumours,
while 3 % were invasive lobular carcinomas, 6 % were mixed
types and 4 % were DCIS. Mean tumour size was 21 mm,
ranging from 6 to 50 mm. None of the 45 patients with
contralateral reduction mammoplasty were determined to
have invasive or in situ carcinoma in the resected breast tissue.
Until November 2011, the median observation period was
26 months, ranging from 11 to 46 months. During this time,
one patient experienced local recurrence of a metaplastic
carcinoma while undergoing chemotherapy and another pa-
tient died from metastatic spread of the disease. One patient
had surgery during the observation period to correct for breast
asymmetry after radiation therapy. The correction was done as
a re-reduction mammoplasty in the contralateral breast.
Surgical strategy
Reconstruction techniques
To obtain a reconstructed breast with a natural shape and
acceptable symmetry to the contralateral breast, volume re-
duction, volume displacement and volume replacement tech-
niques were utilised [9, 12, 14–16, 24–28]. The volume re-
duction technique involves tumour resection along with the
normal tissue resected in a reduction mammoplasty. There-
fore, the partial mastectomy is integrated into the reduction
mammoplasty procedure. Conversely, in the volume displace-
ment technique, the defect after partial mastectomy is filled
with internal flaps of breast tissue, whereas the replacement
technique involves filling the defect with external flaps of
tissue from outside the breast on the thoracic wall. When the
reconstruction was done using the volume reduction or vol-
ume displacement technique, reduction mammoplasty or
mastopexy was simultaneously performed on the contralateral
breast to ensure symmetry.
Tumour size, tumour location and breast size
Several factors, such as tumour size, tumour location, size of
the affected breast and size of the contralateral breast, need to
be considered when planning oncoplastic breast surgery.
Breast size was categorised as small, medium or large. When
using these terms we do not refer to absolute measurements in
volume orweight. The terms rather refer to a clinical judgment
of the relation between the size and location of the tumour on
one hand, and the size of the breast on the other. This interre-
lation determines the expected defect after tumour resection
related to the residual breast volume, and consequently the
feasible techniques for reconstruction. As a clinical norm a
small breast is up to 250 cm3, a medium one 250–500 cm3 and
a large one 500 cm3 or more. Typically, a small breast requires
reconstruction using volume replacement techniques, where
extra mammary tissue is utilised. Reconstruction by volume
replacement may also be an option for medium or large sized
breasts. However, a medium to large breast is more suited for
reconstruction using volume reduction or volume displace-
ment techniques.
Tumour size itself does not have any impact on the decision
to perform an immediate partial reconstruction. Rather, the size
of the tumour relative to the affected breast, that is the size of the
defect after tumour resection in relation to the size of the breast,
determines if an immediate partial reconstruction is feasible. If
so, the location of the tumour also has to be taken into consid-
eration when deciding which method of reconstruction to rec-
ommend. As guidance for planning and evaluation of the
reconstruction we used tumour location in zones I–IX described
by McCulley and Macmillan [12, 14] as shown in Fig. 1.
Surgical planning
In addition to tumour size, tumour location and breast
size, the patient’s acceptance of the recommended
Table 1 Summary of breast cancer-related surgeries for patients treated at
Sydvestjysk Sygehus (Esbjerg) and Privathospitalet Aleris-Hamlet (Co-
penhagen) between January 2008 and December 2010, as well as breast
cancer patients treated at Sygehus Soenderjylland (Aabenraa) from Oc-
tober 2010 to December 2010
Sydvestjysk Sygehus Privathospitalet Aleris-Hamlet Sygehus Soenderjylland
Esbjerg Copenhagen Aabenraa
No. of patients 736 115 95
Mastectomy 283 (38 %) 45 (39 %) 37 (39 %)
Partial mastectomy 409 (56 %) 47 (41 %) 53 (61 %)
Oncoplastic surgery 44 (6 %) 23 (20 %) 5 (5.2 %)
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reconstruction method, including potential donor sites and
the possibility of contralateral breast surgery to ensure
symmetry, was factored into the planning process for
immediate partial reconstruction.
Patients were divided into four groups to facilitate
surgical planning and postoperative evaluation. Group I
included patients with medium to large breasts and
tumours located in zones II–IV, whereas group II
consisted of patients with medium to large breasts and
tumours located in zones V–IX. Group III patients pos-
sessed medium to large breasts and tumours in zone I.
Finally, group IV consisted of patients with small
breasts and tumours in zones I–IX.
Group I: lower region, medium to large breasts (zones II–IV)
In patients with tumours located in the lower lateral, lower
central or lower medial regions (zones II–IV) and medium to
large breasts, the resection and reconstruction was planned as
a volume reduction as part of a reduction mammoplasty as
shown in Fig. 2 [14]. The tumour resection could often be
performed as an en bloc resection with very wide margins. To
ensure symmetry, a contralateral reduction mammoplasty was
performed simultaneously with resection of the same amount
of tissue as in the reconstructed breast.
Fig. 1 Illustration of the distribution of zones in the breast described by
McCulley and MacMillan [14]
Fig. 2 Patient with medium to
large breasts from group I. A 42-
year-old woman with a 15-mm
invasive ductal carcinoma located
in the lower central region of the left
breast (zone III). Weight of
lumpectomy at 80 g, reconstruction
with volume reduction technique
and contralateral reduction
mammoplasty. Preoperative photos
(a, b) and results after radiotherapy
2 years post-surgery (c, d)
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Group II: upper or mid region, medium to large breasts (zones
V–IX)
If tumours were located in the mid or upper region of
the breast (zones V–IX), resection was not possible
within a conventional reduction mammoplasty. In pa-
tients with medium to large breasts, the reconstruction
was planned as a volume displacement of residual
breast tissue (Fig. 3). Most of these reconstructions
were performed as part of a simultaneous reduction
mammoplasty. Al l pat ient s received reduct ion
mammoplasty of the contralateral breast to ensure sym-
metry. Some patients with medium sized breasts who
declined surgery on the contralateral breast were recon-
structed using volume replacement, where the volume of
the reconstructed breast was not altered and contralateral
surgery could be avoided.
Group III: central tumours, medium to large breasts (zone I)
Tumour resection of a central tumour (zone I) involved resec-
tion of tissue, which is not typically included in a regular
reduction mammoplasty. For some patients, it included either
the entire or part of the nipple-areola complex (NAC). For
patients with medium or large breasts, the reconstruction was
planned as a volume displacementof residual breast tissue and
a contralateral reduction mammoplasty (Fig. 4). If tumour
resection included the NAC, nipple reconstruction was per-
formed at the same time or as a delayed procedure.
Group IV: small breast (zones I–IX)
Regardless of tumour location, reconstruction with volume
reduction or volume displacement is not an option for patients
with small breasts because no residual breast tissue would be
Fig. 3 Patient with medium to
large breasts from group II. A 59-
year-old woman with a 17-mm
invasive ductal carcinoma in the
upper region (zone VII) of the left
breast. Weight of lumpectomy at
41 g, reconstruction with volume
displacement technique with
inferior-based extended flap with
skin island and contralateral
reduction mammoplasty. Photos
preoperative (a, b), peroperative (c)
and 3 months postoperative (d, e)
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available for these techniques after tumour resection. As such,
reconstruction after tumour resection was planned as a volume
replacement using external flaps. These patients were planned
for reconstruction with a tunnelled lateral thoracodorsal flap
with skin island [26], a TAP flap [27] or a muscle-sparing
latissimus dorsi flap [28]. Using these methods, the recon-
structed breast maintained the preoperative size and generally
no contralateral surgery was needed (Fig. 5). However, one
patient had a contralateral mastopexy to relocate the position
of the NAC.
Peroperative management
Surgery was performed by a team of breast surgeons working
closely with plastic and reconstructive surgeons. The
responsibilities and tasks of each surgeon were clearly defined
before surgery. The breast surgeon was responsible for the
ablative procedure, including tumour resection and sentinel
node biopsy. If a sentinel node biopsy indicated metastasis or
if metastasis to the axilla was diagnosed preoperatively, the
breast surgeon also performed axillary exaeresis. The plastic
surgeon was responsible for reconstruction and contralateral
reduction mammoplasty or mastopexy. If a contralateral pro-
cedure was required, the operation was performed simulta-
neously with the ablative procedures to minimise time in the
operation room.
Resected tissue was peroperatively examined macroscopi-
cally by a pathologist to ensure free margins. Later, the spec-
imen was evaluated by routine histological methods. The
tumour cavity was marked by metal clips for the orientation
Fig. 4 Patient with medium to
large breasts from group III. A 63-
year-old woman with a 19-mm
invasive ductal carcinoma located
in the central region of the right
breast (zone I). Weight of








preoperative (a, b), peroperative
(c) and 2 years postoperative (d, e)
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of radiation therapy. In order to avoid contamination, the
operation fields were kept strictly separated in cancer and
non-cancer areas including the use of separate instruments.
Postoperative management
During the postoperative period, patients recovered as in-
patients at the Department of Breast Surgery and were usually
discharged after 2–5 days. Post-surgery patients were referred
to adjuvant therapy according national guidelines by the Dan-
ish Breast Cancer Group (DBCG) [29]. Patients were seen by




Surgery was performed as planned with tumour resection,
immediate partial reconstruction and, if needed, contralateral
surgery to ensure symmetry in 73 of 74 procedures. However,
in one patient, the planned breast-conserving procedure had to
be converted to a mastectomy to ensure free margins, due to
DCIS extending more than 50 mm (Table 3). For this patient,
reconstructive surgery using a breast implant was performed
at a later date.
The distribution of patients in groups I to IV, as well as the
methods of reconstruction used for each group, are shown in
Table 2. Tumour resections in group I had a mean specimen
weight of 367 g, ranging from 41 to 1,630 g, which was
considerably larger than tumour resections in group II, III
and IV. The mean weight in group II was 138 g (range from
27 to 463 g), whereas the mean specimen weight in patients
with central tumours in group III was 83 g (ranged from 27 to
124 g). Group IV patients with small breasts had an average
resected tumour weight of 55 g, ranging from 20 to 127 g.
As summarised in Table 2, reconstructions in group I were
all performed using a volume reduction technique with supe-
rior flaps as part of a reductionmammoplasty. Reconstructions
in group II patients with medium to large breasts were done
using either a volume displacement (22/25) or volume re-
placement (3/25) technique involving several different types
of flaps, mostly extended or secondary pedicled flaps. All
patients with central tumours in group III (n=14) had recon-
structions performed using the displacement technique. Sim-
ilarly, all patients with small breasts in group IV (n=17) were
had reconstructions using a volume replacement technique
Fig. 5 Patient with small breasts
from group IV. A 46-year-old
woman with a 25-mm invasive
ductal carcinoma in the lateral
region (zone VI) of the left breast.
Weight of lumpectomy at 40 g,
reconstruction with volume
replacement technique with
tunnelled thoracodorsal flap with
skin island and no contralateral
surgery. Pre- (a, b) and
postoperative photos after
3 months (c, d)
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with different types of external flaps. Overall, 54 patients
(74 %) elected for surgery on the contralateral breast to ensure
symmetry using either a reduction mammoplasty (45/54) or
mastopexy (9/54). Nineteen of 73 patients, including all pa-
tients with small breasts, did not require contralateral breast
surgery since all 19 were reconstructed using a volume re-
placement technique.
Surgical radicality
In 73 of 74 resections, the tumour was resected with free
margins based on peroperative macroscopic evaluation during
the oncoplastic procedures (Table 3). For ten cases (14 %),
peroperative macroscopic evaluation was corrected after post-
operative histological evaluation. In seven cases (10 %), free
margins were achieved by re-resection; whereas three cases
(4 %) required a mastectomy (Table 3).
For 38 patients (51 %), metastasis to axillary lymph nodes
was determined preoperatively or peroperatively after sentinel
node biopsy. Axillary exaeresis was performed at the time of
primary surgery (Table 3). An additional nine patients (12 %)
had positive sentinel node biopsy after postoperativemicroscop-
ic evaluation. Axillary exaeresis was performed at a later date
according to national guidelines by the DBCG [29] (Table 4).
Surgery due to insufficient primary surgery or postoperative
complications
Subsequent surgery performed under general anaesthesia after
primary tumour resection and reconstructive surgery was nec-
essary due to two scenarios. One scenario was insufficient
resection margins or positive sentinel node biopsy after final
microscopic evaluation in 19 patients (26 %) and the second
scenario was postoperative complications in 9 patients (12 %)
(Table 4). Postoperative complications occurred in the recon-
structed breast, the contralateral breast or the axilla when
axillary exaeresis had been performed (Table 5). Haematoma
was the most common complication, which occurs nine times
in seven different patients (10 %).
Table 2 Tumour resections with immediate partial breast reconstruction in relation to tumour location (zones) and size of the breast (small, medium and
large), weight of resection (grammes), methods of reconstruction and contralateral surgery group I–IV
Group: No. Tumour resection weight mean (range) Reconstruction method No. Contralateral surgery
I (medium to large, zones II–IV) 17 367 g (41–1,630) Superior flaps 17 17/17 (100 %)




Tunnelled LT flapa 2
TAP flap 1
III (medium to large, zone l) 14 83 g (27–124) Inferior flaps 13 14/14 (100 %)
Superior flap 1
IV (small breasts, zones I–IX) 17 55 g (20–127) Tunnelled LT flapa 13 1/17 (6 %)
LD flap 3
Rotation flap+LT 1
Total (groups I–IV, zones I–IX) 73 157 (20–1630) 54/73 (74 %)
For 1 of 72 patients, mastectomy was required instead of oncoplastic surgery due to non-radical lumpectomy due to tumour histology
LT lateral thoracodorsal flap; LDmuscle-sparing latissimus dorsi flap
a Tunneled lateral fasciocutan thoracodorsal flap with skin island
Table 3 Primary mastectomies,
primary sufficient resection mar-
gins, primary axillary exaeresis,
secondary mastectomies, re-resec-
tions and secondary axillary
exaeresis after final pathological
evaluation
n=74; where n is the numbers of
breasts with cancer. Two patients
had bilateral cancers
No. of breast Percent
Primary surgery
Mastectomy 1 1.4
Sufficient resection margins peroperative 73 98.6
Peroperative positive sentinel node+axillary exaeresis 38 51.4
Secondary surgery
Insufficient resection margins in final pathological evaluation causing mastectomies 3 4.0
Insufficient resection margins in final pathological evaluation causing re-resection 7 9.5
Late positive sentinel node causing secondary axillary exaeresis 9 12.1
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Adjuvant therapy is according to the DBCG guidelines
planned to begin 4 weeks postoperatively [29]. When com-
plications led to onset beyond 4 weeks the onset was regarded
as delayed. Four patients (6 %) had delayed onset of adjuvant
therapy due to delayed wound healing. The delay was 13, 14,
24 and 50 days respectively.
Discussion
The surgical strategy for oncoplastic breast surgery strives for
radical cancer surgery as well as a good cosmetic and resilient
outcome and by this improving the outcome of breast cancer
surgery. The purpose of the current study was to present an
evaluation of a surgical strategy pertinent to a wide range of
variations in tumour size and location and breast size.
Patients included in the study were comparable to patients
in previous studies examining similar aspects of conventional
breast-conserving surgery with regards to tumour type, loca-
tion and size [11–14, 16–18, 21]. The study cohort included
patients with small to large breasts and tumours of various
sizes and locations within the breast, reflecting the general
variations in breast cancer patients.
The surgical strategy was designed to meet the reconstructive
challenges presented in the whole population of breast cancer
patients. Multiple methods of reconstruction were used, includ-
ing volume reduction, volume displacement and volume replace-
ment techniques, demonstrating that surgeons performing
oncoplastic breast surgery require familiarity and experiencewith
several reconstructive techniques [9, 12–16, 21, 24–28].
If the reconstructed breast was predicted to be markedly
smaller or less ptotic than the contralateral breast, the patient
was offered a contralateral reduction mammaplasty or
mastopexy, which are routinely performed in a many hospitals
[8, 9, 11–16, 20]. It is debated whether or not postoperative
radiation therapy cause subsequent shrinkage due to fibrosis
or chronic oedema leading to an increase in breast volume.
Regardless, both situations would make immediate contralat-
eral surgery inappropriate [8, 9, 30]. During our observation
period of more than 2 years, on average, a supplemental
corrective procedure had to be done just for one patient. This
supports the use of immediate contralateral surgery and is
consistent with previous studies [11, 12, 14, 21].
With our strategy, we had positive resection margins in ten
of our patients (14 %) for which seven (10 %) required re-
resection and three (4 %) required mastectomy. This result is
equal to or better than figures reported in previous studies [11,
12, 17, 18, 21, 31, 32].
One would think that oncoplastic breast surgery with im-
mediate reconstruction involving internal or external flaps and
bilateral surgery would be followed by an increase in postop-
erative complications compared with unilateral breast-
conserving surgery. With our strategy we noted haematomas
requiring surgery in 12 % of cases, of which 5 % were located
in the reconstructed breast, 4 % in the contralateral breast and
3 % in the axilla. No flap necrosis was observed. Results are
consistent with previously reported rates of early postopera-
tive complications [11, 12, 18].
Administration of adjuvant therapy is important for the
optimal treatment of breast cancer. As such, it is important that
complications after surgery do not delay delivery of adjuvant
therapy. Delay of adjuvant therapy occurred in 4 of our patients
(6 %) due to wound healing problems, which have also been
reported in previous studies [9, 11, 12, 18]. Thus, complications
after oncoplastic breast surgery have little negative impact on
the timely administration of adjuvant therapy.
Table 5 Summary of complications observed after oncoplastic surgery
Haematoma Necrosis Seroma Delayed wound healing Infection
Reconstructed breast (n=73) 4 (5.5 %) 1 0 3 0
Donor site (n=20) 0 (0.0 %) 0 0 0 0
Contralateral breast (n=53) 3 (5.6 %) 0 0 2 0
Axilla (n=45) 2 (4.4 %) 0 1 0 1
Total 9 1 1 5 1
One patient had a haematoma on both the reconstructed and contralateral breast after reduction mammoplasty, whereas another patient experienced
delayed wound healing (more than 4 weeks) on both breasts
Table 4 Secondary surgery in general anaesthesia due to complications
and local disease control
Complication Site of complication No Percent
Haematoma Reconstruction 4 (5.4 %)
Contralateral breast 3 (4.1 %)
Axilla 2 (2.7 %)
Disease control
Re-resections 7 (9.5 %)
Axillary exaeresis due to late positive SN 9 (12.3 %)
Mastectomy 3 (4.1 %)
Reoperations total 28 (38.3 %)
n=73. One patient had a haematoma on both the reconstructed and
contralateral breast after reduction mammoplasty, as well as a third
haematoma after re-resection because of insufficient resection margins
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In the realm of our study, 1,018 women had surgery due to
breast cancer. Sixty-two percent had breast-conserving surgery
where 7 % represent oncoplastic surgery (Table 1). The low
percentage of patients operated with oncoplastic surgery indi-
cates that far from all patients that would be suitable for
oncoplastic surgery are presented for this option. This view is
supported by Urban et al. [6] and Baildam [7] who reported that
up to 30 % of patients treated by breast-conserving surgery
experience deformities that require complementary surgery. To
increase the number of oncoplastic breast procedures, the capac-
ity of the breast surgeon to anticipate various reconstruction
methods is essential and underlines the necessity of team work
between breast surgeons and plastic and reconstructive surgeons.
Without the option of oncoplastic surgery, most patients
with tumours in small breasts, and some of the patients with
central tumours would be referred to a mastectomy and even-
tually an immediate or a delayed reconstruction [11, 16].
Especially in these circumstances, our strategy with the use
of external flaps becomes particularly relevant.
In conclusion, it is possible and safe to carry through a
preoperatively planned method for immediate partial breast
reconstruction in a wide range of variations in tumour size,
tumour location and breast size, and this demonstrates the
feasibility to implement oncoplastic breast surgery into daily
clinical practice based on our strategy.
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